Transglutaminase 2 undergoes a large conformational change upon activation.

Human transglutaminase 2 (TG2), a member of a large family of enzymes that catalyze protein crosslinking, plays an important role in the extracellular matrix biology of many tissues and is implicated in the gluten-induced pathogenesis of celiac sprue. Although vertebrate transglutaminases have been...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniel M Pinkas, Pavel Strop, Axel T Brunger, Chaitan Khosla
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2007
Materias:
Acceso en línea:https://doaj.org/article/1807f4db44564b6e8e5268aebe2b45fa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1807f4db44564b6e8e5268aebe2b45fa
record_format dspace
spelling oai:doaj.org-article:1807f4db44564b6e8e5268aebe2b45fa2021-11-25T05:33:32ZTransglutaminase 2 undergoes a large conformational change upon activation.1544-91731545-788510.1371/journal.pbio.0050327https://doaj.org/article/1807f4db44564b6e8e5268aebe2b45fa2007-12-01T00:00:00Zhttps://doi.org/10.1371/journal.pbio.0050327https://doaj.org/toc/1544-9173https://doaj.org/toc/1545-7885Human transglutaminase 2 (TG2), a member of a large family of enzymes that catalyze protein crosslinking, plays an important role in the extracellular matrix biology of many tissues and is implicated in the gluten-induced pathogenesis of celiac sprue. Although vertebrate transglutaminases have been studied extensively, thus far all structurally characterized members of this family have been crystallized in conformations with inaccessible active sites. We have trapped human TG2 in complex with an inhibitor that mimics inflammatory gluten peptide substrates and have solved, at 2-A resolution, its x-ray crystal structure. The inhibitor stabilizes TG2 in an extended conformation that is dramatically different from earlier transglutaminase structures. The active site is exposed, revealing that catalysis takes place in a tunnel, bridged by two tryptophan residues that separate acyl-donor from acyl-acceptor and stabilize the tetrahedral reaction intermediates. Site-directed mutagenesis was used to investigate the acyl-acceptor side of the tunnel, yielding mutants with a marked increase in preference for hydrolysis over transamidation. By providing the ability to visualize this activated conformer, our results create a foundation for understanding the catalytic as well as the non-catalytic roles of TG2 in biology, and for dissecting the process by which the autoantibody response to TG2 is induced in celiac sprue patients.Daniel M PinkasPavel StropAxel T BrungerChaitan KhoslaPublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Biology, Vol 5, Iss 12, p e327 (2007)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Daniel M Pinkas
Pavel Strop
Axel T Brunger
Chaitan Khosla
Transglutaminase 2 undergoes a large conformational change upon activation.
description Human transglutaminase 2 (TG2), a member of a large family of enzymes that catalyze protein crosslinking, plays an important role in the extracellular matrix biology of many tissues and is implicated in the gluten-induced pathogenesis of celiac sprue. Although vertebrate transglutaminases have been studied extensively, thus far all structurally characterized members of this family have been crystallized in conformations with inaccessible active sites. We have trapped human TG2 in complex with an inhibitor that mimics inflammatory gluten peptide substrates and have solved, at 2-A resolution, its x-ray crystal structure. The inhibitor stabilizes TG2 in an extended conformation that is dramatically different from earlier transglutaminase structures. The active site is exposed, revealing that catalysis takes place in a tunnel, bridged by two tryptophan residues that separate acyl-donor from acyl-acceptor and stabilize the tetrahedral reaction intermediates. Site-directed mutagenesis was used to investigate the acyl-acceptor side of the tunnel, yielding mutants with a marked increase in preference for hydrolysis over transamidation. By providing the ability to visualize this activated conformer, our results create a foundation for understanding the catalytic as well as the non-catalytic roles of TG2 in biology, and for dissecting the process by which the autoantibody response to TG2 is induced in celiac sprue patients.
format article
author Daniel M Pinkas
Pavel Strop
Axel T Brunger
Chaitan Khosla
author_facet Daniel M Pinkas
Pavel Strop
Axel T Brunger
Chaitan Khosla
author_sort Daniel M Pinkas
title Transglutaminase 2 undergoes a large conformational change upon activation.
title_short Transglutaminase 2 undergoes a large conformational change upon activation.
title_full Transglutaminase 2 undergoes a large conformational change upon activation.
title_fullStr Transglutaminase 2 undergoes a large conformational change upon activation.
title_full_unstemmed Transglutaminase 2 undergoes a large conformational change upon activation.
title_sort transglutaminase 2 undergoes a large conformational change upon activation.
publisher Public Library of Science (PLoS)
publishDate 2007
url https://doaj.org/article/1807f4db44564b6e8e5268aebe2b45fa
work_keys_str_mv AT danielmpinkas transglutaminase2undergoesalargeconformationalchangeuponactivation
AT pavelstrop transglutaminase2undergoesalargeconformationalchangeuponactivation
AT axeltbrunger transglutaminase2undergoesalargeconformationalchangeuponactivation
AT chaitankhosla transglutaminase2undergoesalargeconformationalchangeuponactivation
_version_ 1718414622067785728